Cart
sales@molnova.com
(D-Phe2·6,Pro3)-LHRH
CAS No. 67019-15-2
(D-Phe2·6,Pro3)-LHRH( ——— )
Catalog No. M40006 CAS No. 67019-15-2
(D-Phe2·6,Pro3)-LHRH
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(D-Phe2·6,Pro3)-LHRH
-
NoteResearch use only, not for human use.
-
Brief Description(D-Phe2·6,Pro3)-LHRH
-
Description(D-Phe2·6,Pro3)-LHRH
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number67019-15-2
-
Formula Weight1193.37
-
Molecular FormulaC59H80N14O13
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(4R,4aS,5R)-2,3,4a,5...
(4R,4aS,5R)-2,3,4a,5,6,7-Hexahydro-4-hydroxy-4a,5-dimethyl-1(4H)-naphthalenone
-
Caffeic Acid Pheneth...
Caffeic Acid Phenethyl Ester (CAPE) inhibits the activation of nuclear transcription factor NF-kappa B and may suppress p70S6K and Akt-driven signaling pathways, with antineoplastic, cytoprotective and immunomodulating activities.
-
2'-Deoxyinosine
it is used to treat HIV infection with other antiviral drugs.
